Successful treatment of relapsed FLT3-mutated donor cell-derived MDS/AML with FLT3 inhibitor gilteritinib
使用 FLT3 抑制剂吉瑞替尼成功治疗复发性 FLT3 突变供体细胞来源的 MDS/AML
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06896-3
Kawano, Mana; Kunimoto, Hiroyoshi; Izumi, Akihiko; Adachi, Akiko; Miura, Ayaka; Yokoyama, Chiaki; Hasegawa, Kodai; Shirafuta, Mayoko; Tanaka, Marika; Sakuma, Takayuki; Ohashi, Takuma; Takahashi, Hiroyuki; Miyazaki, Takuya; Tachibana, Takayoshi; Hagihara, Maki; Matsumoto, Kenji; Nakajima, Hideaki